title: Can we design drugs for HIV/AIDS that are less susceptible to resistance?
authors.affiliation: Department of Biology, Georgia State University, PO Box 4010, Atlanta, GA 30302-4010, USA.
authors.forename: Irene T
authors.initials: IT
authors.lastname: Weber
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015195:Drug Design; D024882:Drug Resistance, Viral; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D009705:Nucleosides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D009705:Nucleosides
keywords: antiretroviral therapy; molecular mechanisms of drug resistance; rational drug design; resistance testing and interpretation